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This case–control study of 310 colorectal cancer cases and 1177 controls in a nested prospective, population-based cohort of
Singapore Chinese subjects found a statistically significant association between the cyclooxygenase (COX)-2  765G4C gene
polymorphism and colon cancer risk among high consumers of dietary n-6 polyunsaturated fatty acids (odds ratio¼2.38, 95%
confidence interval¼1.23–4.59).
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Diet is believed to be the single most important contributor
to colonic carcinogenesis (Tomatis et al, 1990). Experimental
data have shown that saturated fatty acids (SFAs) and
n-6 polyunsaturated fatty acids (PUFAs) have tumour-enhancing
properties in the colon (Reddy and Maeura, 1984; Zhao et al,
1991, Woutersen et al, 1999). Epidemiological data suggest
that increased consumption of all meat or red meat,
which contains high levels of SFAs, is strongly associated
with colorectal cancer (Giovannucci and Goldin, 1997;
Sandhu et al, 2001), but there is only limited evidence on the
role of dietary n-6 PUFAs (Zock and Katan, 1998; Flood et al,
2003).
The putative mechanism through which dietary n-6 PUFAs
may enhance colonic carcinogenesis is the increased formation
of prostaglandins, with the rate-limiting and committal step being
mediated by the cyclooxygenase (COX)-2 enzyme (Dubois
et al, 1998). Prostaglandins possess a wide spectrum of procarci-
nogenic properties (Handler et al, 1990; Cowlen and Eling,
1993; Coffey et al, 1997; Dermott et al, 1999). We therefore
hypothesised that functional COX-2 gene polymorphisms may
impact on the conversion of n-6 PUFAs into prostaglandins, with
consequent change in level of cancer risk. A single nucleotide
polymorphism ( 765G4C) in the promoter region of the COX-2
gene was recently described (Papafili et al, 2002). We therefore
investigated whether this COX-2 gene polymorphism was related to
colorectal cancer risk within a population-based, prospective
cohort of middle-aged and older Chinese men and women in
Singapore.
MATERIALS AND METHODS
Study subjects
The study design and subject recruitment of the Singapore Chinese
Health Study have been described (Hankin et al, 2001). Briefly,
63257 Chinese women and men aged 45–74 years belonging to the
Hokkien or Cantonese dialect group were enrolled in the study
between April 1993 and December 1998. At recruitment, informa-
tion on lifestyle factors and usual diet over the last year was
obtained through in-person interviews. The dietary component of
the questionnaire was validated through a series of 24-h food
recalls (Hankin et al, 2001). Respondents were asked to choose
from predefined frequency and portion size categories for each of
the 165 listed food/beverage items that he/she consumed during
the past 12 months. We used the Singapore Food Composition
Table to estimate average daily intake of 96 nutrient and non-
nutrient compounds for each study subject (Hankin et al, 2001).
The Institutional Review Boards at the University of Southern
California and the National University of Singapore had approved
this study.
We identified incident colorectal cancer cases through
the population-based cancer registry in Singapore (Chia et al,
2000). As of 30 April 2002, 592 colorectal cancer cases had
occurred among cohort participants. All cases (including
one carcinoid tumour and two in situ cancers) were histologically
confirmed except three (ascertained by death records and clinical
evidence). Details of the biospecimen collection, processing
and storage procedures have been described (Koh et al, 2003).
Briefly, we attempted to collect blood and single-void
urine specimens from a random 3% sample of cohort enrollees.
If the subject refused to donate blood, he/she was asked to donate
buccal cells. We collected blood/buccal cell samples from
1194 subjects during April 1994–July 1999. Of these subjects,
13 developed colorectal cancer by 30 April 2002, and the remaining
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study. We also attempted to collect blood/buccal cell and urine
samples from all incident colorectal cancer cases. Of the 592
colorectal cancer cases, 312 (53%) donated blood/buccal cell
samples.
COX-2 genotyping
Genomic DNA was extracted from buffy coats (228 cases and
895 controls) and buccal cell samples (84 cases and 286 controls)
using a QIAamp 96 DNA Blood Kit (Qiagen, Valencia, CA, USA).
A TaqMan assay for the  765G4C COX-2 polymorphism
was developed using a TaqMan PCR Core Reagent kit (Applied
Biosystems Inc., Foster City, CA, USA). The oligonucleotide
primers for amplification of the polymorphic region of COX-2
were GC093 for (50-CATTAACTATTTACAGGGTAACTGCTTAGG-
30) and GC093rev (50-CCCCCTCCTTGTTTCTTGGA-30). In
addition, the fluorogenic oligonucleotide probes (TaqMan
MGB Probes; ABI) used to detect each of the alleles were
GC093F (50-CTTTCCCGCCTCTCT-30) labelled with 6-FAM to
detect the G allele and GC093V (50-CTTTCCCCCCTCTCT-30)
labelled with VIC to detect the C allele. Experimental samples
were compared to 12 controls to identify the three genotypes at
each locus (GG, GC, CC). All samples were processed without
knowledge of their case/control status. Any samples that were
outside the parameters defined by the controls were identified as
noninformative and were retested. Four controls and two cases had
noninformative COX-2 genotypes and were excluded from the
present analysis.
Statistical analysis
Data were analysed by standard methods for unmatched case–
control studies (Breslow and Day, 1980). Unconditional logistic
regression models were used to examine the associations between
COX-2 genotypes and risk of colorectal cancer, and their possible
modification by n-6 PUFA intake. The associations were measured
by odds ratios (ORs) and their corresponding 95% confidence
intervals (CIs) and P-values (two-sided). Limited by the very low
frequency of the CC genotype (0.003), the GC and CC genotypes
were combined when compared with the GG genotype. All ORs
were adjusted for age (year) at recruitment, year of recruitment,
gender, dialect group (Cantonese, Hokkien), level of education (no
formal schooling, primary school, secondary school and higher),
body mass index (o20, 20 to o24, 24 to o28, 28þ kgm
 2),
smoking status (never, exsmoker, current smoker), frequency of
alcohol consumption (nondrinker, monthly drinker, weekly
drinker, daily drinker), and familial history of colorectal cancer
(yes, no).
RESULTS
Of the 592 incident colorectal cancer cases, 282 were excluded from
the present analysis due to unavailable blood/buccal cell samples
(n¼280) or noninformative COX-2 genotype (n¼2). Cases
included in the present study (n¼310) were comparable to those
excluded in terms of age (mean: 65.4 vs 66.1 years), but slightly
different in gender (57 vs 49% male), dialect group (45 vs 37%
Cantonese) and level of education (69 vs 60% attaining primary
school education or higher).
In total, 180 (58%) cases had colon cancer, and the remaining
cases had either rectal or rectosigmoid cancers. Table 1 shows the
distributions of selected characteristics of colorectal cases and
controls. Cases were older, less educated, more obese and more
likely to smoke cigarettes than controls. Intakes of total calories,
total fat, SFAs, monounsaturated fatty acids (MUFAs), PUFAs, n-3
PUFAs, n-6 PUFAs, fibre, calcium or folate were comparable
between cases and controls.
Among control subjects, the G and C allele frequencies of
the COX-2 genotype were 0.952 and 0.048, respectively, and the GG,
GC and CC genotype frequencies were 0.907, 0.090 and 0.003,
respectively. These genotypic distributions were in Hardy–
Weinberg equilibrium (P¼0.43). Overall, there was no association
between colorectal cancer risk and COX-2  765G4C genotype
or n-6 PUFA intake (Table 2). When subjects were stratified into
high (above median) vs low (below median) intake levels of n-6
PUFAs, a borderline statistically significant association between
genotype and risk was observed among high consumers of
n-6 PUFAs (OR¼1.65, 95% CI¼0.95–2.87), which was mainly
confined to colon cancer (OR¼2.38, 95% CI¼1.23–4.59)
(Table 3). There was no association between genotype and
rectal cancer risk regardless of dietary n-6 PUFA intake levels.
There was indication of an interaction effect between COX-2
genotype and dietary n-6 PUFAs in colon cancer (P¼0.07), which
was absent in rectal cancer (P¼0.51). The corresponding P-value
for the gene–diet interaction effect in colorectal cancer combined
was 0.10.
DISCUSSION
In this cohort of Singapore Chinese, we reported a statistically
significant effect of the COX-2  765G4C gene polymorphism on
colon cancer risk among subjects with high intake of dietary n-6
PUFAs. Our data support the hypothesis that COX-2 exerts its
effects on colon carcinogenesis through its influence on pros-
taglandin synthesis from n-6 PUFAs.
The current study has several strengths. (1) Our prospective
study design precludes the possibility of recall bias. Furthermore,
reliable dietary nutrient estimates including n-6 PUFAs were
assessed using a validated food frequency questionnaire. (2) The
nationwide cancer registry has been in place in Singapore since
1968 (Parkin et al, 2002), and migration out of Singapore has been
negligible since inception of the study. This relatively complete
ascertainment of cancer and death outcomes eliminates a concern
for potential selection bias. (3) Study subjects originated from two
contiguous regions in Southern China, resulting in a genetically
homogeneous study population that facilitated the investigation of
gene–disease associations. (4) Exposure information on other
known/suspected risk factors for colorectal cancer was collected
and accounted for in all analyses of gene–diet–cancer risk
associations.
The chief limitation of our study is the lack of information on
use of COX-2 inhibitors, which may bias the effect of COX-2
genotype on risk. However, if use of COX-2 inhibitors were to exert
a confounding effect on the observed COX-2 genotype/colon
cancer association, our inability to control for such confounding is
likely to lead to an underestimation, rather than an overestimation,
of the risk associated with the putative high-activity genotype. This
is because use of COX-2 inhibitors is likely to be more common
among subjects with more severe symptoms of inflammation,
possibly due to the possession of the high activity COX-2 genotype.
Another weakness of the present study is our relatively small
number of cancer cases, which may result in less precise
estimation of risk factor–disease associations.
The major n-6 PUFA in most diet is linoleic acid, the precursor
of arachidonic acid. The latter is consequently converted to various
prostaglandins, and COX is the crucial and rate-limiting enzyme
for this conversion. There is compelling evidence that prostaglan-
dins play important roles in colorectal carcinogenesis by enhan-
cing cell proliferation and growth, promoting angiogenesis and
inhibiting apoptosis (Cao and Prescott, 2002; Stoehlmacher and
Lenz, 2003). COX-2 gene expression and its mRNA and protein
levels were markedly elevated in most human colorectal cancers
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et al, 1995). It is hypothesised that the COX-2-associated effect on
colorectal carcinogenesis is due to the increased production of
prostaglandins from dietary n-6 PUFAs (Eberhart and Dubois,
1995). In support of this hypothesis, high dietary n-6 PUFAs has
been shown to promote colon tumorigenesis by upregulating COX-
2 expression in animal studies (Singh et al, 1997).
The human COX-2 gene is mapped to chromosome 1q25.2–
q25.3 and spans about 8.3kb pairs with 10 exons (Kosaka et al,
1994). Previous studies on the 50 flanking region of the human
COX-2 gene show that this region contains a canonical TATA box
as well as several putative factor elements that are critical in
inducing COX-2 gene transcription, such as Sp1, NF-kB, GRE
(glucocorticoid) and IRE (insulin) elements (Tazawa et al, 1994;
Yang et al, 1997). The region from nucleotide  827 to  454 has
been described as a negative region since deletion of this region led
to increased luciferase activity in reporter expression studies. The
 765G4C mutation lies within this region, and is also within one
of the five putative Sp1 elements (Yang et al, 1997). At present,
data on the functionality of the  765G4C polymorphism and the
direction/magnitude of change in protein expression/activity
between the C and G alleles are limited and mixed (Papafili et al,
2002; Schneider et al, 2003).
In summary, the present study provides the first epidemiological
evidence for a possible cause-and-effect connection between the
production of prostaglandins from n-6 PUFAs through the
enzymatic activity of COX-2, and increased risk of tumour
development in the colon. Our novel findings require confirmation
in larger studies with varying levels of substrate intake and
genotype frequency.
Table 1 Selected characteristics of colorectal cancer cases and controls, the Singapore Chinese Health Study
Characteristics Controls (n¼1177) Cases (n¼310) P-value
a
Mean age7s.d.
b (years) 56.578.1 61.377.5 o0.001
Number (%)
Sex
Males 509 (43.2) 178 (57.4) o0.001
Females 668 (56.8) 132 (42.6)
Dialect group
Cantonese 571 (48.5) 138 (44.5) 0.23
Hokkien 606 (51.5) 172 (55.5)
Level of education
No formal schooling 318 (27.0) 95 (30.6) 0.01
Primary school 504 (42.8) 151 (48.7)
Secondary school 288 (24.5) 54 (17.4)
A level/university 67 (5.7) 10 (3.2)
Body mass index (kgm
 2)
p20 187 (15.9) 46 (14.8) 0.04
20 o24 659 (56.0) 151 (48.7)
24 o28 267 (22.7) 92 (29.7)
28+ 64 (5.4) 21 (6.8)
Cigarette smoking
Never smokers 853 (72.5) 184 (59.4) o0.001
Former smokers 131 (11.1) 52 (16.8)
Current smokers 193 (16.4) 74 (23.9)
Frequency of alcohol consumption
Nondrinkers 964 (81.9) 243 (78.4) 0.14
Monthly 85 (7.2) 21 (6.8)
Weekly 93 (7.9) 29 (9.4)
Daily 35 (3.0) 17 (5.5)
Familial history of colorectal cancer
No 1149 (97.6) 297 (95.8) 0.12
Yes
c 28 (2.4) 13 (4.2)
Median (5th percentile, 95th percentile)
Total calories (kcalday
 1) 1483.5 (829.9, 2477.5) 1494.0 (819.3, 2589.2) 0.54
Total fat (gday
 1) 40.5 (19.6, 81.7) 39.8 (19.0, 77.1) 0.66
SFAs (gday
 1) 14.0 (5.9, 30.0) 13.7 (5.8, 29.2) 0.62
MUFAs (gday
 1) 13.6 (6.3, 28.0) 13.4 (6.1, 26.5) 0.88
PUFAs (gday
 1) 8.1 (3.3, 18.6) 7.9 (3.4, 16.5) 0.74
N-3 PUFAs (gday
 1) 0.8 (0.4, 1.7) 0.8 (0.4, 1.7) 0.94
N-6 PUFAs (gday
 1) 7.2 (2.9, 16.8) 7.0 (3.0, 14.9) 0.75
Fiber (gday
 1) 12.2 (5.0, 23.1) 11.9 (4.3, 22.5) 0.83
Calcium (mgday
 1) 373.5 (156.7, 853.5) 363.4 (158.8, 773.6) 0.56
Folate (mgday
 1) 146.0 (64.1, 277.7) 147.1 (57.9, 286.9) 0.65
aTwo-sided P-values derived from t-test (for age), w
2 test (for categorical variables) or Wilcoxon rank sum test (for nutrient intakes).
bMean age at recruitment into the cohort,
s.d.¼standard deviation.
cAny of first-degree relatives had colorectal cancer.
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